The expansion of the market for life science instruments and reagents owes much to pharmaceutical and biotechnology companies' escalating investments in research and development (R&D) initiatives.
Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, ...
STAMFORD, Conn.--(BUSINESS WIRE)--Technologies that enable decentralized clinical trials and other new practices are transforming the global life sciences industry, according to a new research report ...
The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large corporates, although the nature of that opportunity is evolving. There has ...
LOS ANGELES--(BUSINESS WIRE)--BioTools Innovator (BTI), the first accelerator focused exclusively on life science tools and diagnostics startups, has selected 30 companies for its 2026 Accelerator ...
A recent move by the Trump administration to substantially lower funding from the National Institutes of Health for research institutions around the country has investors fearing meaningful losses for ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Overview: AI and genomics are creating new career pathways across India's evolving life science sector.Bioinformatics and ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and ...
—Tailored mentorship to help startups compete for $300,000 in funding— BioTools Innovator (BTI), the first accelerator focused exclusively on life science tools and diagnostics startups, has selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results